The nephrology and urology incontinence devices market encompasses a range of medical devices used to manage urinary incontinence associated with kidney disorders, prostate surgery, aging-related bladder dysfunction, and neurological conditions. These devices include urinary catheters, urethral slings, artificial urinary sphincters, external collection systems, and electrical stimulation units.
Growing awareness, an aging population, and an increase in chronic kidney and urological conditions are fueling global demand for both clinical-grade and home-use continence solutions.
In 2025, the market is projected to reach approximately USD 602.1 million, and is expected to grow to around USD 882.8 million by 2035, reflecting a Compound Annual Growth Rate (CAGR) of 3.9% over the forecast period.
Key Market Metrics
| Metric | Value |
|---|---|
| Market Size in 2025 | USD 602.1 Million |
| Projected Market Size in 2035 | USD 882.8 Million |
| CAGR (2025 to 2035) | 3.9% |
This growth is driven by the rise in chronic diseases, advancements in non-invasive incontinence therapies, and broader adoption of continence devices in both hospital and home settings.
Explore FMI!
Book a free demo
It also dominates the market, with high diagnosis and treatment rates and advanced reimbursement systems, as well as the presence of companies including Boston Scientific, Medtronic, and Coloplast. There have also been increasing use of home-use external catheters and male continence devices in the United States, driven by a growing aging male populations and the growing number of post-prostatectomy patients.
Europe is driven by aging demographics, increasing recognition of pelvic floor disorders, and long-term disease management opportunities for public health programs. Sling systems, electrical stimulation therapies, and long-term catheterization solutions are among the products available in Germany, UK, and France, which are considered to be the key markets in Europe. A drive for standardization in continence care is also evident in EU initiatives.
The fastest-growing region is Asia-Pacific, including countries like Japan, China, South Korea, and India, where an aging population, increasing access to healthcare services, and government support for elder care are contributors to boosting growth in the market. Urban hospitals are pouring money into high end incontinence implants but rural centers lean toward low end disposables.
Stigma, Reimbursement Gaps, and Limited Awareness in Emerging Markets
The market for the devices are still experiencing challenges which have been ongoing such as social stigma regarding incontinence particularly in the older generation and also among women. Many patients do not seek medical help out of embarrassment or simply do not know that they can get non-invasive treatment.
Moreover, reimbursement schemes for incontinence devises (eg, external catheters, pelvic floor stimulators, or urethral slings) differ widely from country to country, restricting access in low-income/publicly funded health care systems. In addition, in emerging markets, the scarcity of urologists and geriatric medicine experts makes it difficult for patients to embrace newer, minimally invasive solutions and patient education initiatives.
Aging Population, Technological Advancements, and Remote Patient Monitoring
Despite the barriers, due to cultural and structural factors, the market is rapidly growing because of the increasing global older population, especially in North America, Europe, Japan and South Korea, where urinary incontinence (UI) and chronic kidney disease (CKD) are prevalent.
Smart wearable pelvic floor stimulators, adjustable continence control implants and wireless bladder sensors are among innovations transforming urology care. Home-based management and remote patient monitoring solutions also are presenting a ‘new front’ for device manufacturers. Moreover, growing emphasis on quality-of-life outcomes, less invasive surgical options, and personalized urology care pathways are changing the market dynamics.
From 2020 to 2024, the market was supported by the increasing use of disposable external devices, catheterization products, and non-surgical therapies for urinary incontinence and fecal incontinence. Nonetheless, innovation was mostly restricted to incremental progress and device access in developing nations continued low.
Between 2025 and 2035, we will transition to digitally connected, patient-centric devices that enable real-time monitoring, AI-driven alerts, and integrated data for nephrologists and urologists. Gender-specific solutions, reusable smart devices, and biofeedback-enabled wearables will take root alongside traditional alternatives in acute care and home care settings.
Market Shifts: A Comparative Analysis 2020 to 2024 vs. 2025 to 2035
| Market Shift | 2020 to 2024 Trends |
|---|---|
| Regulatory Landscape | Approval driven by clinical safety and hygiene standards |
| Technology Innovations | Focused on catheters, external drainage systems, and static implants |
| Market Adoption | Dominated by hospitals, rehabilitation centers, and elder care homes |
| Sustainability Trends | Early efforts in biocompatible materials and low-waste packaging |
| Market Competition | Led by Coloplast , Boston Scientific, B. Braun, Hollister, Teleflex, Medtronic |
| Consumer Trends | Demand for discretion, comfort, and reliability |
| Market Shift | 2025 to 2035 Projections |
|---|---|
| Regulatory Landscape | Inclusion of cybersecurity guidelines, patient data compliance, and AI risk mitigation |
| Technology Innovations | Expansion into AI-enabled pelvic floor stimulators, smart sensors, and bioelectronics devices |
| Market Adoption | Expansion into home-based therapy, tele-urology, and senior wellness tech platforms |
| Sustainability Trends | Growth in reusable device ecosystems, biodegradable disposables, and eco-certified production |
| Market Competition | Entry of medtech startups , telehealth-integrated device firms, and wearable health tech players |
| Consumer Trends | Shift toward invisible wearables, app-connected devices, and gender-specific comfort designs |
In North America, there is an increase in the nephrology and urology incontinence devices market, owing to the prevalence of chronic kidney disease (CKD), prostate-related ailments, and urge/pressure incontinence among the geriatric population.
The rising awareness initiatives, the coverage by Medicare, and the increasing prevalence of home-based healthcare are propelling adoption of the intermittent catheters, external drainage systems, and implanted neuromodulator devices. Big healthcare systems are moving toward managing urology patients as outpatients, providing opportunity for innovation in portable, patient-friendly incontinence products.
| Country | CAGR (2025 to 2035) |
|---|---|
| USA | 4.1% |
A key driver of the UK market are NHS programs intended to improve urological care in hospitals and care homes, alongside growing uptake of urinary slings, drainage bags, and electrical stimulation therapies for bladder control.
There is now much greater awareness of male and female incontinence in the community, leading to earlier diagnosis and management. Additionally, clinical guidelines promoting non-invasive and rehabilitative management of urinary dysfunction are driving an increase in the adoption of minimally invasive, patient enemy operated, and reusable devices particularly for older adults and post-surgical patients.
| Country | CAGR (2025 to 2035) |
|---|---|
| UK | 3.8% |
Germany, France, and Italy are expected to provide special focus on nephrology and urology incontinence devices market owing to aging population and increased access to incontinence urology home care facilities in the region.
Favorable reimbursement systems and hospital discharge programs are catalyzing high demand for self-catheterization, male external catheters, and pelvic floor stimulation devices. Minimally invasive methods for bladder control and smart wearable technologies are gaining traction among the tech-forward healthcare providers in the region.
| Country | CAGR (2025 to 2035) |
|---|---|
| EU | 3.7% |
Japan’s incontinence device market is an outgrowth of one of the world’s fastest-aging populations. The expansion of geriatric care has led to increased use of indwelling catheters, continence care kits, portable urine collectors, and neuromodulator systems for bladder control.
Japan, with its high clinical standards and focus on the prevention of infection and the comfort of users, represents one of the key adopters of next-generation silicone-based and antimicrobial-coated incontinence solutions. There’s an increasing demand for such treatment across long-term care facilities and rehabilitation centers, especially in Tokyo and Osaka.
| Country | CAGR (2025 to 2035) |
|---|---|
| Japan | 3.9% |
South Korea’s market is witnessing growth owing to high burden of chronic urinary conditions, and diabetic nephropathy coupled with increasing government support for elder care services. With an increase in female urethral slings, disposable catheters, and external collection systems in hospitals and homecare settings.
The country’s advanced tech healthcare ecosystem is also embracing connected continence management devices that allow patient tracking to improve comfort and reduce hospital visits. As South Korea’s population gets older, the need for dignified, low-disruption solutions rises ever more.
| Country | CAGR (2025 to 2035) |
|---|---|
| South Korea | 3.8% |
| By Type | Market Share (2025) |
|---|---|
| Dialysis Devices and Equipment | 40% |
In the nephrology and urology incontinence devices market, the dialysis devices and equipment segment held a massive share of around 40% of the total market. This is mainly due to the growing incidence of end-stage renal disease (ESRD) and chronic kidney disease (CKD) across the globe. The global population is aged and shit like hypertension, diabetes, and other lifestyle-related maladies are on the rise, along with the incidence of kidney-related diseases requiring proper renal replacement therapies.
Over the years technological advances have greatly improved the function and safety of such devices like automated peritoneal dialysis machines and wearable dialysis (great improvements in function and safety scoring concluding in people with improved outcomes and quality of life).
Additionally, a rise in government support initiatives, along with increased healthcare expenditure for improved access to dialysis services, drives the growth of this segment. For example, several countries have established reimbursement policies and funding schemes to reduce the financial cost of long-term dialysis treatment for patients. The growth of dialysis centers and the implementation of telemedicine has also enabled remote patient monitoring and management, especially in underrepresented areas.
But the segment is not without its challenges, including expensive dialysis machines and a shortage of skilled health care professionals who can operate it and maintain those devices. Manufacturers are working towards cost-effective and user-friendly solutions to tackle these challenges, whereas healthcare institutions are investing in training sessions to improve the capabilities of the medical staff.
Overall, relatively high renal replacement therapies demand, technological advancement, and supportive healthcare policies constitution a significant share of this segment. It is expected that continued efforts to improve affordability and accessibility will sustain growth across this segment in the coming years.
| By End User | Market Share (2025) |
|---|---|
| Hospitals and Clinics | 70% |
On the basis of end-user segment, hospitals and clinics remains the most prominent end-user in the global nephrology and urology incontinence devices market, accounting for roughly 70% share of overall market. Such medical institutes provide specialized nephrology and urology services, including intervention, diagnosis, and treatment for various types of kidney and urinary tract disorders. Being at the forefront of patient care, they are the primary user of incontinence devices and auxiliary equipment.
Hospitals and clinics can accurately diagnose patients and customize treatment plans using advanced diagnostic tools, including imaging systems and laboratory services. From routine consultations to advanced surgical interventions, they provide comprehensive hospital and outpatient services covering all levels of care. Additionally, these academic centers often have clinical trials and research programs that bring the latest devices and therapies to more patients.
Chronic Kidney Diseases, Urinary Disorder, and an Aging Population Requiring Specialized Care Fuel segment's Dominance. Multidisciplinary models of care have also emerged, and these are seen in many hospitals and clinics, involving nephrologists, urologists, nurses, and allied health professionals working together in an integrated manner to optimize management of patients with kidney disease. Simply put, the access to urgent care and critical care units allows for immediate intervention in cases of worsening health, and this is what makes you the cornerstone of health system.
But this space suffers from things like resource shortages, staffing shortages, balancing cost to care. To toll relief, healthcare leaders are implementing value-based care models, investing in staff education, and utilizing health information technologies to achieve operational efficiencies and improved patient outcomes.
The nephrology and urology incontinence devices market is advancing steadily due to the growing prevalence of urinary incontinence, chronic kidney disease (CKD), bladder dysfunction, and age-related urological conditions.
Demand is being driven by the aging population, rising surgical interventions, increased awareness of pelvic floor disorders, and the development of minimally invasive, comfortable, and wearable devices. The market is also driven by technological advancements, especially in wireless monitoring, biofeedback systems, and reusable device formats.
Market Share Analysis by Key Players
| Company/Organization Name | Estimated Market Share (%) |
|---|---|
| Boston Scientific Corporation | 18-22% |
| Coloplast A/S | 14-18% |
| Medtronic plc | 12-16% |
| Becton, Dickinson and Company (BD) | 10-14% |
| Hollister Incorporated | 8-12% |
| Others | 26-32% |
| Company/Organization Name | Key Offerings/Activities |
|---|---|
| Boston Scientific Corporation | In 2025, Boston Scientific launched the updated AMS 800™ artificial urinary sphincter, designed for long-term male incontinence, and expanded its Axonics ® neuromodulator system for overactive bladder and retention cases. |
| Coloplast A/S | As of 2024, Coloplast released the Altis ® single-incision sling system and improved male incontinence products, focusing on post-prostatectomy patients and chronic urological care. |
| Medtronic plc | In 2024, Medtronic integrated InterStim ™ X sacral neuromodulator system with smart controllers, allowing personalized bladder control therapies with low maintenance and rechargeable battery life. |
| BD (Becton, Dickinson and Company) | In 2024, BD expanded its urology catheter portfolio, emphasizing hydrophilic-coated and intermittent catheters for both nephrology clinics and home-based patients. |
| Hollister Incorporated | Hollister enhanced its continence care product line with discreet male external catheters, drainage systems, and skin-friendly adhesives tailored for long-term wearers. |
Key Market Insights
Boston Scientific Corporation (18-22%)
Boston Scientific leads with a diverse portfolio of implants and neurostimulation systems, offering advanced continence restoration and bladder modulation therapies used in hospitals and specialized urology centers worldwide.
Coloplast A/S (14-18%)
Coloplast is widely trusted for surgical and non-surgical incontinence solutions, including pelvic floor repair systems and indwelling catheters, with a strong presence in Europe, Australia, and North America.
Medtronic plc (12-16%)
Medtronic’s neuromodulator-based urology devices cater to patients with overactive bladder and non-obstructive urinary retention, supported by physician programming tools and wireless patient interfaces.
Becton, Dickinson and Company (10-14%)
BD focuses on patient safety and infection prevention, offering a comprehensive range of nephrology-friendly catheters and urological disposables, especially in hospital and outpatient dialysis centers.
Hollister Incorporated (8-12%)
Hollister specializes in personal continence management, supplying self-catheterization systems, external wearables, and ostomy-compatible solutions, commonly used by long-term and mobility-impaired users.
Other Key Players (26-32% Combined)
Many regional and niche companies are enriching the nephrology and urology incontinence space with wearable tech, smart devices, and user-centered innovations, including:
The overall market size for nephrology and urology incontinence devices market was USD 602.1 million in 2025.
The nephrology and urology incontinence devices market is expected to reach USD 882.8 million in 2035.
Growing aging population, rising incidence of kidney and bladder disorders, and increasing adoption of minimally invasive incontinence management solutions will drive market growth.
The top 5 countries which drives the development of nephrology and urology incontinence devices market are USA, European Union, Japan, South Korea and UK.
Hospitals and clinics expected to grow to command significant share over the assessment period.
Nephrology and Urology Incontinence Devices Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
